108 related articles for article (PubMed ID: 37356137)
21. Poly (lactic-co-glycolic acid) nanoparticle-based vaccines delivery systems as a novel adjuvant for H9N2 antigen enhance immune responses.
Wusiman A; Zhang Y; Ayihengbieke T; Cheng X; Kudereti T; Liu D; Wang D; Abula S
Poult Sci; 2022 May; 101(5):101791. PubMed ID: 35358927
[TBL] [Abstract][Full Text] [Related]
22. A Multiepitope Peptide, rOmp22, Encapsulated in Chitosan-PLGA Nanoparticles as a Candidate Vaccine Against
Du X; Xue J; Jiang M; Lin S; Huang Y; Deng K; Shu L; Xu H; Li Z; Yao J; Chen S; Shen Z; Feng G
Int J Nanomedicine; 2021; 16():1819-1836. PubMed ID: 33707942
[TBL] [Abstract][Full Text] [Related]
23. Molecular docking of immunogenic peptide of Toxoplasma gondii and encapsulation with polymer as vaccine candidate.
Cakir-Koc R; Budama-Kilinc Y; Kokcu Y; Kecel-Gunduz S
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):744-754. PubMed ID: 29741393
[TBL] [Abstract][Full Text] [Related]
24. Intracellular Activity of Poly (DL-Lactide-co-Glycolide) Nanoparticles Encapsulated with Prothionamide, Pyrazinamide, Levofloxacin, Linezolid, or Ethambutol on Multidrug-Resistant
Jiang H; Li X; Xing Z; Niu Q; Xu J
Curr Drug Deliv; 2023; 20(3):306-316. PubMed ID: 35546770
[TBL] [Abstract][Full Text] [Related]
25. Anti-inflammatory loaded poly-lactic glycolic acid nanoparticle formulations to enhance myocardial gene transfer: an in-vitro assessment of a drug/gene combination therapeutic approach for direct injection.
Fargnoli AS; Mu A; Katz MG; Williams RD; Margulies KB; Weiner DB; Yang S; Bridges CR
J Transl Med; 2014 Jun; 12():171. PubMed ID: 24934216
[TBL] [Abstract][Full Text] [Related]
26. PLGA Nanoparticle-Based Dissolving Microneedle Vaccine of
Wan W; Li Y; Wang J; Jin Z; Xin W; Kang L; Wang J; Li X; Cao Y; Yang H; Wang J; Gao S
Toxins (Basel); 2023 Jul; 15(7):. PubMed ID: 37505730
[TBL] [Abstract][Full Text] [Related]
27. Long-acting inhalable chitosan-coated poly(lactic-co-glycolic acid) nanoparticles containing hydrophobically modified exendin-4 for treating type 2 diabetes.
Lee C; Choi JS; Kim I; Oh KT; Lee ES; Park ES; Lee KC; Youn YS
Int J Nanomedicine; 2013; 8():2975-83. PubMed ID: 23976850
[TBL] [Abstract][Full Text] [Related]
28. A biodegradable polymeric system for peptide-protein delivery assembled with porous microspheres and nanoparticles, using an adsorption/infiltration process.
Alcalá-Alcalá S; Urbán-Morlán Z; Aguilar-Rosas I; Quintanar-Guerrero D
Int J Nanomedicine; 2013; 8():2141-51. PubMed ID: 23788833
[TBL] [Abstract][Full Text] [Related]
29. Characterization of a multi-epitope peptide with selective MHC-binding capabilities encapsulated in PLGA nanoparticles as a novel vaccine candidate against Toxoplasma gondii infection.
Roozbehani M; Falak R; Mohammadi M; Hemphill A; Razmjou E; Meamar AR; Masoori L; Khoshmirsafa M; Moradi M; Gharavi MJ
Vaccine; 2018 Oct; 36(41):6124-6132. PubMed ID: 30181047
[TBL] [Abstract][Full Text] [Related]
30. Employing ATP as a New Adjuvant Promotes the Induction of Robust Antitumor Cellular Immunity by a PLGA Nanoparticle Vaccine.
Zhang Q; Huang W; Yuan M; Li W; Hua L; Yang Z; Gao F; Li S; Ye C; Chen Y; He J; Sun W; Yang X; Bai H; Ma Y
ACS Appl Mater Interfaces; 2020 Dec; 12(49):54399-54414. PubMed ID: 33215918
[TBL] [Abstract][Full Text] [Related]
31. A novel antigen of Mycobacterium tuberculosis and MPLA adjuvant co-entrapped into PLGA:DDA hybrid nanoparticles stimulates mucosal and systemic immunity.
Khademi F; Derakhshan M; Yousefi-Avarvand A; Najafi A; Tafaghodi M
Microb Pathog; 2018 Dec; 125():507-513. PubMed ID: 30352265
[TBL] [Abstract][Full Text] [Related]
32. Sub-unit vaccine against S. aureus-mediated infections: set-up of nano-sized polymeric adjuvant.
Colonna C; Dorati R; Conti B; Caliceti P; Genta I
Int J Pharm; 2013 Aug; 452(1-2):390-401. PubMed ID: 23707885
[TBL] [Abstract][Full Text] [Related]
33. Enhancement of Th1 immune response against Leishmania cysteine peptidase A, B by PLGA nanoparticle.
Noormehr H; Zavaran Hosseini A; Soudi S; Beyzay F
Int Immunopharmacol; 2018 Jun; 59():97-105. PubMed ID: 29649772
[TBL] [Abstract][Full Text] [Related]
34. Non-carrier nanoparticles adjuvant modular protein vaccine in a particle-dependent manner.
Seth A; Ritchie FK; Wibowo N; Lua LH; Middelberg AP
PLoS One; 2015; 10(3):e0117203. PubMed ID: 25756283
[TBL] [Abstract][Full Text] [Related]
35. Preferential tumor accumulation and desirable interstitial penetration of poly(lactic-co-glycolic acid) nanoparticles with dual coating of chitosan oligosaccharide and polyethylene glycol-poly(D,L-lactic acid).
Wang G; Chen Y; Wang P; Wang Y; Hong H; Li Y; Qian J; Yuan Y; Yu B; Liu C
Acta Biomater; 2016 Jan; 29():248-260. PubMed ID: 26476340
[TBL] [Abstract][Full Text] [Related]
36. The effect of poloxamer 188 on nanoparticle morphology, size, cancer cell uptake, and cytotoxicity.
Yan F; Zhang C; Zheng Y; Mei L; Tang L; Song C; Sun H; Huang L
Nanomedicine; 2010 Feb; 6(1):170-8. PubMed ID: 19447200
[TBL] [Abstract][Full Text] [Related]
37. PLGA particulate subunit tuberculosis vaccines promote humoral and Th17 responses but do not enhance control of Mycobacterium tuberculosis infection.
Ashhurst AS; Parumasivam T; Chan JGY; Lin LCW; Flórido M; West NP; Chan HK; Britton WJ
PLoS One; 2018; 13(3):e0194620. PubMed ID: 29554138
[TBL] [Abstract][Full Text] [Related]
38. Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen.
Slütter B; Bal S; Keijzer C; Mallants R; Hagenaars N; Que I; Kaijzel E; van Eden W; Augustijns P; Löwik C; Bouwstra J; Broere F; Jiskoot W
Vaccine; 2010 Aug; 28(38):6282-91. PubMed ID: 20638455
[TBL] [Abstract][Full Text] [Related]
39. Induction of Robust Immune Responses by CpG-ODN-Loaded Hollow Polymeric Nanoparticles for Antiviral and Vaccine Applications in Chickens.
Lin SY; Yao BY; Hu CJ; Chen HW
Int J Nanomedicine; 2020; 15():3303-3318. PubMed ID: 32494131
[TBL] [Abstract][Full Text] [Related]
40. Antigen delivery by lipid-enveloped PLGA microparticle vaccines mediated by in situ vesicle shedding.
Hanson MC; Bershteyn A; Crespo MP; Irvine DJ
Biomacromolecules; 2014 Jul; 15(7):2475-81. PubMed ID: 24894061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
